Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
126806942	12680694	2	F	20150331	20160802	20160824	20160921	EXP		CN-BAYER-2016-161415	BAYER		49.00	YR	A	F	Y	0.00000		20160921		MD	CN	CN

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
126806942	12680694	1	PS	NEXAVAR	SORAFENIB	1	Oral	200 MG, BID	D	21923	200	MG	FILM-COATED TABLET	BID
126806942	12680694	2	SS	NEXAVAR	SORAFENIB	1	Oral	400 MG, BID	D	21923	400	MG	FILM-COATED TABLET	BID
126806942	12680694	3	SS	NEXAVAR	SORAFENIB	1	Oral	200 MG, BID	D	21923	200	MG	FILM-COATED TABLET	BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
126806942	12680694	1	Hepatocellular carcinoma
126806942	12680694	2	Hepatocellular carcinoma
126806942	12680694	3	Hepatocellular carcinoma

Outcome of event

Event ID	CASEID	OUTC COD
126806942	12680694	DE
126806942	12680694	HO

Reactions reported

Event ID	CASEID	PT
126806942	12680694	Ascites
126806942	12680694	Death
126806942	12680694	Portal vein thrombosis
126806942	12680694	Tumour thrombosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
126806942	12680694	1	20141109
126806942	12680694	2	20141203	20150331
126806942	12680694	3	20150331